European Companies Search Engine
Managing Director: Clemens Jilek · ppa: J. B., Th. L. · No longer MD: L. P.-L. · Capital: €25,500 · Name: CVI - Cardiovascular Institute GmbH · Company statute · Corporate Purpose Hrb 2 Feb 2021 German Trade Register Announcements, Germany (01/02/2021)
Overview
Text
HRB 163666: Servicegesellschaft München Süd mbH,
Munich, Am Isarkanal 36, 81379 München
. The Shareholders' Meeting of 20 January 2021 decided to increase the share capital by EUR 500.00 and to recast the Articles of Association. The change was made: company, object of the company, share capital. New company: CVI - Cardiovascular Institute GmbH. New business objective: promoting and conducting scientific studies and collecting data in the field of human medicine to increase knowledge of disease-causing processes and review new treatment methods; investigation of new standards in the quality of data collection; carrying out medical training, patient information and patient education, as well as participation and participation in this area; Special scientific achievements within the framework of the social purpose can be rewarded with prizes and scholarships; Advice, research and development in the medical field, but without treatment services. New share capital: EUR 25,500.00. Retired: Managing Director: Panteleit-Langbein, Lisa Ruth, Gelsenkirchen, *??.??.????. Appointed: Managing Director: PD Dr. Jilek, Clemens, Berg, *??.??.????, authorized to represent one person; with the power to enter into legal transactions on behalf of the company a.s. a representative of a third party. Individual procuratorate: Dr. Brachmann, Johannes, Coburg, *??.??.????; Dr. Lewalter, Thorsten, Wörthsee, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: CVI - Cardiovascular Institute GmbH, Munich, Germany.